Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.92 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
| ▸ | TACR1 | P25103 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diethylcarbamazine SCHEMBL1819685 | 0.96 | HTR1A (1.00) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| Diethylcarbamazine SCHEMBL67289 | 0.96 | HTR1A (1.00) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| Diethylcarbamazine SCHEMBL10412471 | 0.94 | HTR1A (0.96) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| SCHEMBL11096507 | 0.90 | HTR1A (0.89) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| Diethylcarbamazine SCHEMBL27894397 | 0.87 | HTR1A (0.82) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| SCHEMBL11506548 | 0.86 | HTR1A (0.74) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| Diethylcarbamazine SCHEMBL28938729 | 0.85 | HTR1A (0.79) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| Diethylcarbamazine SCHEMBL2319899 | 0.85 | HTR1A (0.79) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| Stearic Acid SCHEMBL10523823 | 0.84 | HTR1A (0.66) | HTR1AKDM4EALDH1A1TSHRLMNA | |
| Diethylcarbamazine SCHEMBL37735 | 0.83 | KDM4E (0.94) | HTR1AKDM4EALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12253460-B2 | Drug detection using cobalt thiocyanate and Eosin Y | BOWLING GREEN STATE UNIVERSITY (US) | 2025-03-18 | — | — | US | disclosed |
| US-12037326-B2 | Diaryl-azole compound and formulation for controlling harmful organism | NIPPON SODA CO., LTD. (JP) | 2024-07-16 | — | — | US | disclosed |
| CN-111565716-B | Method of using dipivefrin | 因斯格尼斯疗法有限公司 | 2023-06-09 | — | — | CN | disclosed |
| US-20230137342-A1 | DRUG DETECTION USING COBALT THIOCYANATE AND EOSIN Y | BOWLING GREEN STATE UNIVERSITY (US) | 2023-05-04 | — | — | US | disclosed |
| EP-3514146-B1 | DIARYL- AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | NIPPON SODA CO (JP) | 2022-03-16 | — | — | EP | disclosed |
| US-20220033384-A1 | DIARYL-AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | NIPPON SODA CO., LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| US-20220000112-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| US-11180485-B2 | Diaryl-azole compound and formulation for controlling harmful organism | NIPPON SODA CO., LTD. (JP) | 2021-11-23 | — | — | US | disclosed |
| EP-0334516-A2 | Method for enhancing the unrolling of a rolled matrix device | PFIZER INC. (US) | 1989-09-27 | — | — | EP | disclosed |
| EP-0334521-A2 | Rolled matrix device having enhanced ability to unroll and method for its production | PFIZER INC. (US) | 1989-09-27 | — | — | EP | disclosed |
| US-4861596-A | LAMINATES, MORANTEL, DRUG DELIVERY | PFIZER INC. (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0294993-A1 | A generic zero order controlled drug delivery system | PFIZER INC. (US) | 1988-12-14 | — | — | EP | disclosed |
| EP-0239039-A2 | Intraruminal controlled release device | SYNTEX (U.S.A.) INC. (US) | 1987-09-30 | — | — | EP | disclosed |
| EP-0010987-B1 | DEVICE FOR ORAL ADMINISTRATION TO A RUMINANT ANIMAL | BEECHAM GROUP PLC (GB) | 1983-10-05 | — | — | EP | disclosed |
| US-4308250-A | FOR ORAL ADMINISTRATION TO RUMINANTS | BEECHAM GROUP LIMITED (GB) | 1981-12-29 | — | — | US | disclosed |
| US-4268497-A | ETHYLENE-VINYL ACETATE COPOLYMER SHEET, APERTURED ENVELOPE, RUMINANTS | BEECHAM GROUP LIMITED (GB) | 1981-05-19 | — | — | US | disclosed |
| US-4228149-A | Sustained release compositions | BEECHAM GROUP LIMITED (GB) | 1980-10-14 | — | — | US | disclosed |
| EP-0010987-A1 | Device for oral administration to a ruminant animal | BEECHAM GROUP PLC (GB) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033384-A1 | DIARYL-AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | CRY1, CRKL, CDC5L | HTR1A 2843/4885KDM4E 3663/4885ALDH1A1 1972/4885 |
| US-12037326-B2 | Diaryl-azole compound and formulation for controlling harmful organism | CRY1, CRKL, CDC5L | HTR1A 2843/4885KDM4E 3663/4885ALDH1A1 1972/4885 |
| US-20220000112-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NOX1, L3MBTL1, MRM1 | HTR1A 2578/4885KDM4E 3309/4885ALDH1A1 114/4885 |
| US-11180485-B2 | Diaryl-azole compound and formulation for controlling harmful organism | CRY1, CRKL, CDC5L | HTR1A 2843/4885KDM4E 3663/4885ALDH1A1 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.